OakChart

CryoPort Inc

CYRXIndustrials·Integrated Freight & Logistics·USA·Small·NASD·Nov 11 • 3:59 PM ET

20.56-0.18 (-0.87%)
2026-11-12 00:39 CET
Market cap
1,051.53 USD m
Revenue, TTM
192.44 USD m
Net income, TTM
-45.09 USD m
Free cash flow, TTM
-18.81 USD m
EPS diluted, TTM
-0.90
P/E
-
Compare

Price

CYRX against its 20, 50 and 200-day averages
2050200miss
10.0015.0020.001.5M3.0MVolumeMay 26Jun 26Jul 26Aug 26Sep 26Oct 26Nov 26CYRXclose 20.5620-day 17.9750-day 17.26200-day 13.6120.5652w high

5.6% under the 52-week high of 21.78 on 11 Nov 2026. 52-week low 7.61 on 3 Mar 2026. Last 15 sessions, 40.4% high to low

Volume 1.45× normal · the line is the 50-bar volume average

Profile

CYRX
52-week range, 97% of the way up
7.6120.99

Cryoport, Inc. engages in the provision of logistics solutions to the life science industry. It also provides logistics solutions for biologic materials such as immunotherapies, stem cells, CAR-T cells, and reproductive cells for clients worldwide, including points-of-care, clinical research organizations central laboratories, biopharmaceuticals, contract manufacturing, health centers, and university researchers. It offers personalized medicine, immunotherapies, cellular therapies, CAR T-cell therapies, stem cell therapies, vaccines, diagnostic materials, semen, eggs, embryos, cord blood, bio-pharmaceuticals, infectious substances, and other commodities that require continuous exposure to certain ranges of precision-controlled temperatures. The company was founded on May 25, 1990 and is headquartered in Brentwood, TN.

IndexRUT
Employees738
IPOJan 31, 2005
Beta1.84
ATR, 14d1.13
Rel volume1.45
Short float7.17%
Insider own4.39%
Inst own90.87%

Snapshot

6 groups

Valuation

IndexRUT
Market Cap1.04B
Enterprise Value929.10M
Income-45.09M
Sales192.44M
Book/sh8.59
Cash/sh7.75
Dividend Est.-
Dividend TTM-
Dividend Ex-Date-
Dividend Gr. 3/5Y- -
Payout-
Employees738
IPOJan 31, 2005

Ratios

P/E-
Forward P/E-
PEG-
P/S5.42
P/B2.39
P/C2.65
P/FCF-
EV/EBITDA-
EV/Sales4.83
Quick Ratio1.94
Current Ratio2.04
Debt/Eq0.48
LT Debt/Eq0.08
Option/ShortYes / Yes

Earnings

EPS (ttm)-0.90
EPS next Y-0.67
EPS next Q-0.17
EPS this Y-161.67%
EPS next Y22.39%
EPS next 5Y-
EPS past 3/5Y-0.23% 13.68%
Sales past 3/5Y-9.45% 17.49%
EPS Y/Y TTM21.02%
Sales Y/Y TTM1.15%
EPS Q/Q-47.16%
Sales Q/Q13.54%
EarningsNov 05 AMC
EPS/Sales Surpr.-41.32% 3.20%

Ownership

Insider Own4.39%
Insider Trans-10.33%
Inst Own90.87%
Inst Trans4.06%
ROA-4.86%
ROE-7.44%
ROIC-7.08%
Gross Margin40.16%
Oper. Margin-20.02%
Profit Margin-23.43%
SMA2014.42%
SMA5019.09%
SMA20051.11%
Trades-

Technical

Shs Outstand50.69M
Shs Float48.47M
Short Float7.17%
Short Ratio4.21
Short Interest3.48M
52W High20.99 -2.05%
52W Low7.61 170.17%
Volatility9.04% 5.61%
ATR (14)1.13
RSI (14)66.25
Beta1.84
Rel Volume1.45
Avg Volume825.67K
Volume1,196,728

Performance

Perf Week23.11%
Perf Month21.30%
Perf Quarter35.89%
Perf Half Y55.17%
Perf YTD114.17%
Perf Year132.32%
Perf 3Y78.63%
Perf 5Y-72.69%
Perf 10Y843.12%
Recom1.22
Target Price22.33
Prev Close20.74
Price20.56
Change %-0.87%

Analyst ratings

latest 10 of 20
DateActionAnalystRating changeTargetImplied
Aug 06, 2025UpgradeLLeerink PartnersMarket Perform → Outperform$16-22.2%
Aug 06, 2025UpgradeKKeyBanc Capital MarketsSector Weight → Overweight
Jul 22, 2025ResumedSStephensOverweight$13-36.8%
Mar 24, 2025UpgradeUUBSNeutral → Buy$10-51.4%
Dec 19, 2024InitiatedGGuggenheimBuy$11-46.5%
Aug 07, 2024DowngradeJJefferiesBuy → Hold$20 → $8-61.1%
Jul 31, 2024UpgradeRB. Riley SecuritiesNeutral → Buy$19 → $15-27.0%
May 03, 2024DowngradeRB. Riley SecuritiesBuy → Neutral$22 → $19-7.6%
Apr 04, 2024ResumedJJefferiesBuy$17 → $21+2.1%
Mar 13, 2024ReiteratedNNeedhamBuy$19 → $18-12.5%

Peers

Mkt cap
TickerCompanyMkt cap
FWRDForward Air Corp581.89M
AZTAAzenta Inc2.14B
UPSUnited Parcel Service Inc95.75B
RLGTRadiant Logistics Inc457.58M
EXPDExpeditors International Of Washington Inc25.12B
FDXFedex Corp75.56B
CORCencora Inc66.77B
TMOThermo Fisher Scientific Inc265.92B
AVTRAvantor Inc10.66B
CRLCharles River Laboratories International Inc16.42B

Insider trading

latest 14 of 29
InsiderRelationshipDateTransactionCostSharesValueTotal heldForm
MARK SAWICKIOfficerNov 10 '26Proposed Sale19.9310,000199,261Nov 10 05:13 PM
DANIEL M HANCOCKDirectorNov 09 '26Proposed Sale19.1074,3791,420,639Nov 09 04:30 PM
SHELTON JERRELLPresident, CEOAug 11 '26Sale14.9128,800429,3851,201,814Aug 11 06:49 PM
JERRELL W SHELTONDirectorAug 11 '26Proposed Sale14.8228,800426,816Aug 11 04:31 PM
ZECCHINI EDWARD JChief Digital and Tech OfficerJun 11 '26Option Exercise4.8033,600161,280143,319Jun 12 06:38 PM
ZECCHINI EDWARD JChief Digital and Tech OfficerJun 10 '26Option Exercise4.801,4006,720111,119Jun 12 06:38 PM
ZECCHINI EDWARD JChief Digital and Tech OfficerJun 11 '26Sale14.4733,600486,239109,719Jun 12 06:38 PM
ZECCHINI EDWARD JChief Digital and Tech OfficerJun 10 '26Sale15.231,40021,324109,719Jun 12 06:38 PM
EDWARD ZECCHINIOfficerJun 11 '26Proposed Sale14.4733,600486,239Jun 11 04:09 PM
EDWARD ZECCHINIOfficerJun 10 '26Proposed Sale15.231,40021,324Jun 10 04:15 PM
STEFANOVICH ROBERTChief Financial OfficerJun 04 '26Sale16.27169,4272,756,984109,850Jun 08 09:11 PM
Mandalam RamkumarDirectorJun 08 '26Sale15.4423,214358,45267,894Jun 08 09:05 PM
RAMKUMAR MANDALAMDirectorJun 08 '26Proposed Sale15.4423,214358,452Jun 08 04:17 PM
STEFANOVICH ROBERTOfficerJun 04 '26Proposed Sale16.50169,4272,795,546Jun 03 04:35 PM

Held by

AUM
TickerCompanyAUM
IWMiShares Russell 2000 Index FundAUM: 77.38B
VTIVanguard Morningstar Total Stock Market ETFAUM: 687.42B
VXFVanguard Extended Market Index ETFAUM: 30.47B
IWNiShares Russell 2000 Value ETFAUM: 14.10B
DFASU.S. Small Cap Portfolio-ETF Class SharesAUM: 15.51B
SCHASchwab U.S. Small-Cap ETFAUM: 22.25B
DFACU.S. Core Equity 2 Portfolio-ETF Class SharesAUM: 49.14B
VTWOVanguard Russell 2000 Index ETFAUM: 16.75B
VFMOVanguard U.S. Momentum Factor ETFAUM: 1.82B
DFMCU.S. Micro Cap Portfolio ETF Class SharesAUM: 212.10M

News

latest 14 of 200
  • Cryoport Misses On EPS But Beats On Revenue And Raises Guidance Again, While Its Regulatory Catalyst Calendar Keeps Shrinking (Earnings Whispers) +19.00%
  • Cryoport Reports Third Quarter 2026 Financial Results (PR Newswire)
  • Cryoport's Profit Turn Faces Its First Test With The Stock Near A Breakout (Earnings Whispers)
  • Cryoport to Report Third Quarter 2026 Financial Results on November 5, 2026 (PR Newswire)
  • CryoPort Inc (CYRX) (Q2 2026) Earnings Call Highlights: Positive EBITDA Milestone and 15% ... (GuruFocus.com)
  • Cryoport Reports Second Quarter 2026 Financial Results (PR Newswire)
  • Cryoport to Report Second Quarter 2026 Financial Results on August 6, 2026 (PR Newswire)
  • Cryoport's IntegriCell Cryopreservation Services Selected by Verismo Therapeutics to Support Clinical KIR-CAR T Cell Therapy Programs (PR Newswire)
  • Cryoport Reports First Quarter 2026 Financial Results (PR Newswire) +19.39%
  • Cryoport to Report First Quarter 2026 Financial Results on May 4, 2026 (PR Newswire)
  • CryoPort Inc (CYRX) Q4 2025 Earnings Call Highlights: Record Growth in Cell and Gene Therapy Revenue (GuruFocus.com)
  • CryoPort Q4 Earnings Call Highlights (MarketBeat)
  • CryoPort, Inc. (CYRX) Reports Q4 Loss, Tops Revenue Estimates (Zacks)
  • Cryoport Reports Fourth Quarter and Full-Year 2025 Financial Results (PR Newswire)

Quarterly earnings

actual against estimate
PeriodReportedEPS actEPS estEPS repSales actSales estAnalysts
2026Q32026-11-05-0.250-0.177-0.25050.2248.669
2026Q22026-08-06-0.200-0.193-0.20348.9748.189
2026Q12026-05-04-0.250-0.216-0.22947.8044.869
2025Q42026-03-03-0.270-0.210-0.21245.4542.859
2025Q32025-11-04-0.180-0.223-0.17244.2341.207
2025Q22025-08-052.050-0.263-0.26845.4541.666
2025Q12025-05-07-0.280-0.345-0.28041.0440.214
2024Q42025-03-04-0.420-0.293-0.41759.5358.509
2024Q32024-11-07-0.020-0.309-0.02456.6658.068
2024Q22024-08-06-1.620-0.397-1.62157.6057.569
2024Q12024-05-07-0.430-0.345-0.42654.5958.789
2023Q42024-03-12-1.310-0.283-1.31557.2658.393
2023Q32023-11-08-0.310-0.318-0.31256.1655.249
2023Q22023-08-09-0.420-0.237-0.41857.0258.299
2023Q12023-05-04-0.160-0.193-0.15762.8262.159
2022Q42023-02-23-0.240-0.205-0.23660.3658.268

Annual earnings

PeriodEPS actEPS estEPS repSales actSales est
2019FY-0.550-0.597-0.54933.9433.90
2020FY-1.940-0.654-1.94578.7074.38
2021FY-6.180-0.603-6.178222.61223.85
2022FY-0.930-0.880-0.925237.28235.17
2023FY-2.210-1.090-2.208233.26234.55
2024FY-2.490-2.372-2.488228.39227.42
2025FY1.4001.3881.400176.18173.63
2026FY--0.863--198.05
2027FY--0.670--218.15
2028FY--0.510--239.43
2029FY--0.450--257.4
2030FY--0.340--281

Estimate revisions

last 14 periods
PeriodTypeDateEstimatesUpDownMeanLowHigh
2026Q4S2026-11-0999051.0650.3051.60
2026Q4S2026-11-0698050.9650.0051.60
2026Q4S2026-11-0590050.0449.5250.36
2026Q4S2026-10-2290050.0449.5250.36
2026Q4S2026-10-2190050.0449.5250.45
2026Q4S2026-09-1493150.0449.5250.45
2026Q4S2026-08-0793150.0449.5250.45
2026Q4S2026-07-1990049.9749.4050.45
2026Q4S2026-06-0592249.9749.4050.45
2026Q4S2026-06-0292249.9849.4050.45
2026Q4S2026-06-0192249.9749.4050.45
2026Q4S2026-05-1892249.9749.4050.45
2026Q4S2026-05-0597249.9749.4050.45
2026Q4S2026-04-1597050.0149.3851.00

Estimate history

EPS, annual-0.34-0.339-0.549-1.945-6.178-0.925-2.208-2.488-0.932-0.8982
Period201720182019202020212022202320242025TTM
EPS, quarterly-0.024-0.417-0.28-0.268-0.172-0.212-0.229-0.203-0.254
PeriodQ3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Sales, annual11.95419.62633.94278.696222.608237.277233.255156.769176.177192.44
Period201720182019202020212022202320242025TTM
Sales, quarterly56.66459.53241.0445.45444.23345.4547.79848.97150.22
PeriodQ3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Shares, annual25.70230.31937.3439.83749.61648.33448.97149.90849.85150.686
Period201720182019202020212022202320242025MRQ
Shares, quarterly49.43149.90850.13750.27950.06949.85150.19850.64850.686
PeriodQ3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26

Income statement, annual

Currency USD, millions
MetricTTM2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY
Total Revenue192.44176.18156.77233.25237.28222.6178.7033.9419.63
Cost of Goods Sold Incl. D&A115.16105.7899.68150.21148.47140.4849.0316.599.39
Gross Profit77.2870.4057.0983.0588.8182.1329.6617.3510.24
Selling, General and Administrative Excl. Other115.81112.34116.13141.69118.5595.5548.5134.7618.88
Research and Development17.9617.0417.7118.0415.7216.849.483.741.84
Other Operating Expense0.000.000.000.000.000.000.000.000.00
Operating Income-38.52-41.94-59.03-58.64-29.74-13.42-18.85-17.41-8.64
Interest Expense2.102.363.985.506.144.692.561.370.07
Unusual Expense4.25-6.6445.0349.5313.57257.5510.320.37-
Net Income Before Taxes-35.13-32.17-104.35-99.35-35.09-273.84-32.74-18.27-9.54
Income Taxes1.931.800.360.242.241.69-0.040.060.02
Consolidated Net Income-37.06-33.97-104.71-99.59-37.33-275.53-32.69-18.33-9.56
Net Income From Continuing Operations-37.06-33.97-104.71-99.59-37.33-275.53-32.69-18.33-9.56
Net Income-45.09-46.65-122.76-107.59-45.33-283.72-75.03-18.33-9.56
EPS (Recurring)-0.83-1.02-1.85-1.50-0.73-2.25-1.76-0.54-0.34
EPS (Basic, Before Extraordinaries)-0.90-0.93-2.49-2.21-0.93-6.18-1.94-0.55-0.34
EPS (Diluted)-0.90-0.93-2.49-2.21-0.93-6.18-1.94-0.55-0.34
EBITDA-12.71-16.79-35.47-31.16-6.976.82-8.98-14.99-7.79
Non-Operating Income (Expense)9.755.493.6914.3214.361.82-1.010.87-0.82
Other After Tax Adjustments0.000.000.000.000.000.000.000.000.00
Stock Option Compensation Expense7.567.9513.0918.0215.8615.356.5112.064.33
Price To Sales Ratio4.582.732.453.243.5812.2121.5116.1915.85
Gross Margin40.1639.9636.4235.6037.4336.8937.7051.1252.18
Operating Margin-20.02-23.80-37.66-25.14-12.53-6.03-23.95-51.29-44.05
Net Margin-23.43-26.48-78.30-46.12-19.11-127.45-95.34-54.01-48.69
Shares Outstanding50.6949.8549.9148.9748.3349.6239.8437.3430.32
Market Capitalization1,051.531,051.53384.57758.45850.152,739.321,740.44589.99322.52

Income statement, quarterly

Currency USD, millions
Metric2026Q32026Q22026Q12025Q42025Q32025Q22025Q12024Q4
Total Revenue50.2248.9747.8045.4544.2345.4541.0459.53
Cost of Goods Sold Incl. D&A29.6929.5528.9826.9426.1127.1825.5036.41
Gross Profit20.5319.4218.8118.5118.1218.2815.5423.12
Selling, General and Administrative Excl. Other29.3429.4928.4428.5428.0227.9030.2037.57
Research and Development4.734.853.914.474.524.123.934.16
Other Operating Expense0.000.000.000.000.000.000.000.00
Operating Income-8.80-10.07-9.63-10.03-9.89-9.62-14.66-14.45
Interest Expense0.520.520.430.630.530.620.580.64
Unusual Expense3.62-0.621.050.21-1.060.08-5.841.83
Net Income Before Taxes-10.66-7.75-9.32-7.39-6.53-11.74-8.79-18.65
Income Taxes0.190.510.111.130.170.270.230.03
Consolidated Net Income-10.85-8.26-9.43-8.52-6.70-12.01-9.03-18.68
Net Income From Continuing Operations-10.85-8.26-9.43-8.52-6.70-12.01-9.03-18.68
Net Income-12.85-10.26-11.43-10.55-8.64-13.48-13.98-20.68
EPS (Recurring)-0.20-0.21-0.21-0.21-0.19-0.27-0.36-0.39
EPS (Basic, Before Extraordinaries)-0.25-0.20-0.23-0.21-0.17-0.27-0.28-0.42
EPS (Diluted)-0.25-0.20-0.23-0.21-0.17-0.27-0.28-0.42
EBITDA-2.34-3.48-3.23-3.67-3.48-2.32-7.01-6.55
Non-Operating Income (Expense)2.282.211.783.472.83-1.430.61-1.74
Other After Tax Adjustments0.000.000.000.000.000.000.000.00
Stock Option Compensation Expense1.851.901.891.922.001.622.423.49
Price To Sales Ratio4.584.252.262.712.501.851.411.69
Gross Margin40.8939.6639.3640.7340.9840.2137.8738.84
Operating Margin-17.53-20.56-20.15-22.06-22.37-21.16-35.72-24.27
Net Margin-25.59-20.94-23.92-23.21-19.53-29.66-34.07-34.73
Shares Outstanding50.6950.6550.2049.8550.0750.2850.1449.91
Market Capitalization1,051.53791.32412.81480.66474.64374.02303.46384.57

Balance sheet, annual

Currency USD, millions
Metric2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY
Cash & Short Term Investments411.21250.60456.75523.32628.8093.3294.3047.2615.04
Short Term Receivables33.3625.3042.0743.8639.4131.387.103.541.63
Inventories23.1921.4826.2127.6816.5010.540.470.220.11
Other Current Assets8.4244.1910.089.328.8011.931.100.750.52
Total Current Assets476.17341.57535.11604.18693.52147.16102.9651.7717.30
Net Property, Plant & Equipment125.17119.93117.5190.4869.7044.0816.294.362.51
Total Investments and Advances0.000.000.000.000.000.000.000.000.00
Intangible Assets160.48168.50302.79342.13348.38359.1916.180.140.09
Deferred Tax Assets1.070.840.668.814.911.971.23--
Other Assets2.0972.651.681.021.371.980.440.350.36
Total Assets764.99703.49957.741,046.611,117.88554.37137.1056.6220.26
Short Term Debt Incl. Current Port. of LT Debt189.8118.165.813.913.602.290.690.020.00
Accounts Payable14.0814.9926.0527.0527.6824.342.501.711.26
Other Current Liabilities15.1231.4113.759.9011.368.392.271.330.93
Total Current Liabilities219.0264.5645.6140.8542.6535.025.463.062.19
Long Term Debt40.91224.38410.20432.00423.45128.634.1114.740.00
Provision for Risks Charges0.000.000.000.000.000.000.000.000.00
Deferred Tax Liabilities1.350.802.8212.798.937.851.25--
Other Liabilities1.0711.8410.105.131.030.180.000.270.19
Total Liabilities262.35301.59468.72490.77476.05171.6710.8218.072.38
Non-Equity Reserves0.000.000.000.000.000.000.000.000.00
Preferred Stock - Carrying Value42.2734.2726.2718.2710.282.840.000.000.00
Common Equity460.36367.62462.75537.56631.55379.85126.2838.5517.89
Total Shareholders Equity502.64401.90489.02555.84641.83382.70126.2838.5517.89
Accumulated Minority Interest0.000.000.000.000.000.000.000.000.00
Total Equity502.64401.90489.02555.84641.83382.70126.2838.5517.89
Total Liabilities & Stockholders Equity764.99703.49957.741,046.611,117.88554.37137.1056.6220.26
Book Value Per Share9.237.379.4511.1212.739.543.381.270.70
Tangible Book Value Per Share6.023.993.274.045.710.522.951.270.69
Full-Time Employees7381,1861,1701,0248476251259257
Price to Book Ratio2.421.001.481.564.654.604.878.6812.20
Return on Assets-4.63-12.61-9.94-3.45-32.95-9.46-18.93-24.86-55.67
Return on Equity-7.51-23.51-19.06-6.23-53.79-12.85-22.24-33.87-67.03
Return on Invested Capital-7.11-18.32-11.07-3.78-25.86-6.39-14.06-17.93-44.16
Quick Ratio2.074.9611.1614.1115.883.9018.7716.847.86
Current Ratio2.175.2911.7314.7916.264.2018.8616.917.92

Cash flow, annual

Currency USD, millions
MetricTTM2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY
Net Income-41.3078.30-114.76-99.59-37.33-275.53-32.69-18.33-9.56
Depreciation23.2525.1523.5727.4922.7720.259.872.420.86
Other Funds (Non Cash)29.48-98.3483.4872.5441.14270.3710.2117.576.83
Funds from Operations11.685.78-8.09-1.5426.1615.32-13.111.67-1.87
Extraordinary Item0.000.000.000.000.000.000.000.000.00
Changes in Working Capital-0.69-14.36-8.230.78-28.01-7.19-1.75-2.99-1.49
Cash from Operating Activities11.00-8.58-16.32-0.76-1.858.13-14.87-1.32-3.35
Capital Expenditures-30.87-19.50-21.27-44.90-24.20-25.01-9.67-5.41-2.96
Net Assets From Acquisitions0.000.00-0.31-7.34-6.55-5.54-363.14-20.32-
Sale of Fixed Assets and Businesses0.00210.240.000.000.000.000.000.00-
Purchase or Sale of Investments48.0059.59198.4087.31-31.93-438.71-9.50-37.20-9.92
Purchase of Investments0.000.00-50.72-42.68-163.79-482.71-158.74-43.20-9.92
Sale Or Maturity of Investments48.0059.59249.12129.99131.8644.00149.236.000.00
Other Uses0.000.000.000.000.000.000.000.000.00
Other Sources0.000.000.000.983.000.000.000.000.00
Cash from Investing Activities17.13250.32176.8136.05-59.68-469.25-382.31-62.93-12.88
Cash Dividends Paid0.000.000.000.000.000.000.000.000.00
Change in Capital Stock-0.61-6.042.791.48-35.91527.73274.7774.1723.83
Repurchase of Common Pref Stock-2.01-10.010.000.00-37.960.000.000.000.00
Sale of Common Pref Stock1.403.972.791.482.05527.73274.7774.1723.83
Proceedsfrom Stock Options0.000.000.000.000.00518.74265.3868.8117.81
Issuance or Reduction of Debt, Net-0.59-15.04-164.32-25.28-3.2636.61110.81-0.0214.70
Change in Long Term Debt-0.59-15.04-164.32-25.28-3.2636.61110.81-0.0214.70
Issuance of Long Term Debt0.000.000.000.000.0040.07110.880.0014.71
Reduction of Long Term Debt-0.59-15.04-164.32-25.28-3.26-3.46-0.07-0.02-0.01
Net Financing Active Other Cash Flow0.000.000.000.000.000.000.000.000.00
Other Financing Activities Uses0.000.000.000.000.000.000.000.000.00
Cash from Financing Activities-1.20-21.07-161.53-23.80-39.17564.34385.5874.1538.53
Exchange Rate Effect-3.56-15.46-0.02-1.74-1.80-0.991.230.01-0.01
Net Change in Cash23.37205.21-1.069.75-102.51102.23-10.369.9122.28
Free Cash Flow-18.81-25.02-33.58-39.54-23.96-15.76-23.78-6.66-6.27
Preferred Dividends (Cash Flow)-------0.000.00
Deferred Taxes & Investment Tax Credit-0.66-0.38-1.98-0.410.23-0.500.020.00

Balance sheet, quarterly

Currency USD, millions
Metric2026Q32026Q22026Q12025Q42025Q32025Q2
Cash & Short Term Investments393.08396.69403.63411.21421.31425.98
Short Term Receivables36.0036.4539.0033.3634.9133.41
Inventories22.4421.5121.7523.1923.3323.04
Other Current Assets5.195.556.158.425.297.07
Total Current Assets456.70460.20470.54476.17484.84489.49
Net Property, Plant & Equipment135.84134.84129.10125.17123.46119.77
Total Investments and Advances0.000.000.000.000.000.00
Intangible Assets155.31158.06160.86160.48163.66162.30
Deferred Tax Assets1.101.061.071.070.270.27
Other Assets2.002.042.052.092.102.10
Total Assets750.95756.20763.61764.99774.33773.93
Short Term Debt Incl. Current Port. of LT Debt190.97190.23189.61189.814.554.32
Accounts Payable16.3516.2515.9414.0813.8814.76
Other Current Liabilities16.8614.5619.3215.1212.3111.08
Total Current Liabilities224.18221.04224.87219.0230.7530.15
Long Term Debt40.5441.7940.8840.91226.31224.21
Provision for Risks Charges0.000.000.000.000.000.00
Deferred Tax Liabilities1.751.851.581.350.660.98
Other Liabilities0.960.831.291.073.343.19
Total Liabilities267.43265.50268.62262.35261.06258.54
Non-Equity Reserves0.000.000.000.000.000.00
Preferred Stock - Carrying Value48.2746.2744.2742.2740.2738.27
Common Equity435.24444.42450.71460.36473.00477.12
Total Shareholders Equity483.51490.70494.99502.64513.27515.39
Accumulated Minority Interest0.000.000.000.000.000.00
Total Equity483.51490.70494.99502.64513.27515.39
Total Liabilities & Stockholders Equity750.95756.20763.61764.99774.33773.93
Book Value Per Share8.598.778.989.239.459.49
Tangible Book Value Per Share5.525.655.776.026.186.26
Full-Time Employees---738--
Price to Book Ratio2.421.750.901.021.001.03
Return on Assets-4.86-4.30-5.01-4.94-6.29-4.79
Return on Equity-7.44-6.54-8.20-8.02-9.96-8.50
Return on Invested Capital-2.07-1.55-1.76-1.57-0.90-1.55
Quick Ratio1.941.982.002.0715.0115.47
Current Ratio2.042.082.092.1715.7716.24

Cash flow, quarterly

Currency USD, millions
Metric2026Q32026Q22026Q12025Q42025Q32025Q2
Net Income-10.85-8.26-10.54-11.64-3.25105.18
Depreciation6.476.596.403.806.427.30
Other Funds (Non Cash)8.603.656.1811.050.34-110.79
Funds from Operations4.072.252.283.083.212.79
Extraordinary Item0.000.000.000.000.000.00
Changes in Working Capital1.14-1.121.46-2.16-1.02-10.13
Cash from Operating Activities5.211.133.730.922.19-7.34
Capital Expenditures-5.83-9.81-10.28-4.94-4.28-6.20
Net Assets From Acquisitions0.000.000.000.000.000.00
Sale of Fixed Assets and Businesses0.000.000.000.000.00210.24
Purchase or Sale of Investments10.004.0029.005.0018.5926.00
Purchase of Investments0.000.000.000.000.000.00
Sale Or Maturity of Investments10.004.0029.005.0018.5926.00
Other Uses0.000.000.000.000.000.00
Other Sources0.000.000.000.000.000.00
Cash from Investing Activities4.17-5.8118.720.0614.31230.04
Cash Dividends Paid0.000.000.000.000.000.00
Change in Capital Stock0.370.800.23-2.01-2.72-1.31
Repurchase of Common Pref Stock0.000.000.00-2.01-3.75-4.26
Sale of Common Pref Stock0.370.800.23-0.001.022.95
Proceedsfrom Stock Options0.000.000.000.000.000.00
Issuance or Reduction of Debt, Net-0.15-0.15-0.14-0.14-0.15-14.55
Change in Long Term Debt-0.15-0.15-0.14-0.14-0.15-14.55
Issuance of Long Term Debt0.000.000.000.000.000.00
Reduction of Long Term Debt-0.15-0.15-0.14-0.14-0.15-14.55
Net Financing Active Other Cash Flow0.000.000.000.000.000.00
Other Financing Activities Uses0.000.000.000.000.000.00
Cash from Financing Activities0.220.650.09-2.15-2.87-15.86
Exchange Rate Effect0.320.38-0.12-4.14-1.23-10.78
Net Change in Cash9.91-3.6522.42-5.3212.39196.06
Free Cash Flow-0.04-7.97-6.25-4.55-1.26-11.70

Revenue breakdown

BioLogistics Solutions2024: 67.02M 2025: 78.14M
BioStorage/BioServices2024: 15.03M 2025: 18.36M
Product2024: 74.73M 2025: 79.68M
Americas2024: 113.55M 2025: 131.26M
Asia Pacific2024: 16.20M 2025: 19.78M
EMEA2024: 27.02M 2025: 25.13M
Life Sciences Products2024: 71.43M 2025: 75.15M
Life Sciences Services2024: 85.34M 2025: 101.03M

Short interest

shares short against float, oldest to newest
SettlementOf floatShares shortFloatAvg volume
2026-10-307.17%3.5M48.5M667.15K
2026-10-155.23%2.5M48.4M631.04K
2026-09-304.88%2.4M48.4M605.03K
2026-09-155.75%2.8M48.4M626.67K
2026-08-315.60%2.7M48.4M710.58K
2026-08-145.20%2.5M48.4M782.57K
2026-07-315.17%2.5M48.4M830.43K
2026-07-155.24%2.5M48.1M798.14K
2026-06-304.52%2.2M48.2M754.98K
2026-06-154.56%2.2M48.2M686.65K
2026-05-294.83%2.3M48.0M609.95K
2026-05-153.96%1.9M48.0M500.46K
2026-04-304.59%2.2M48.0M424.72K
2026-04-154.73%2.3M47.7M407.77K
2026-03-314.55%2.2M47.7M394.16K
2026-03-134.74%2.3M47.7M381.24K
2026-02-274.96%2.4M47.7M386.62K
2026-02-135.37%2.6M47.9M436.30K
2026-01-305.84%2.8M47.9M496.23K
2026-01-156.18%3.0M47.9M610.64K

Option chain

expiry 2026-11-20
TypeStrikeBidAskLastIVOpen intVolumeDeltaThetaVega
call2.5017.2019.6013.9718.0653.000.000.995-0.0180.000
call5.0014.7017.100.0010.7770.000.000.961-0.1220.003
call7.5012.2014.600.007.7960.000.000.942-0.1240.004
call10.0010.0012.006.405.7411.000.000.919-0.1200.005
call12.507.509.503.474.3775.000.000.891-0.1120.006
call15.004.707.004.903.2661,1570.000.851-0.1010.007
call17.503.003.303.500.9953,6910.000.784-0.0850.009
call20.000.901.401.031.34988.001.000.595-0.1110.012
call22.500.000.850.351.22540.000.000.358-0.0850.012
call25.000.000.750.201.65121.000.000.265-0.0980.010
call27.500.000.750.382.0571.000.000.228-0.1130.010
call30.000.000.750.252.40010.000.000.205-0.1240.009
call32.500.000.750.002.6981.000.000.190-0.1330.009
put2.500.000.050.006.3090.000.00-0.005-0.0160.001
put5.000.000.750.007.9700.000.00-0.039-0.1220.003
put7.500.000.750.005.8190.000.00-0.058-0.1230.004
put10.000.000.750.104.3811,0000.00-0.081-0.1190.005
put12.500.000.750.553.28517.000.00-0.109-0.1110.006
put15.000.000.750.102.3772,3540.00-0.149-0.1000.007
put17.500.000.700.351.5704570.00-0.216-0.0830.009
put20.000.001.852.951.6962.000.00-0.405-0.1090.012
put22.500.903.503.301.8201.000.00-0.642-0.0820.012
put25.002.704.900.001.3830.000.00-0.735-0.0960.010
put27.505.507.400.001.7670.000.00-0.772-0.1100.010
put30.008.009.900.002.0920.000.00-0.795-0.1210.009
put32.5010.5012.800.002.8560.000.00-0.810-0.1290.009

Latest SEC filings

30
FiledFormDescriptionPeriodLink
2026-11-10144Filing for proposed sale of securities under Rule 144.SEC
2026-11-09144Filing for proposed sale of securities under Rule 144.SEC
2026-11-0510-QQuarterly report pursuant to Section 13 or 15(d)2026-09-30SEC
2026-11-058-KCurrent report2026-11-05SEC
2026-08-14SCHEDULE 13G/ASEC
2026-08-13SCHEDULE 13G/ASEC
2026-08-11144Filing for proposed sale of securities under Rule 144.SEC
2026-08-114Statement of changes in beneficial ownership of securities2026-08-11SEC
2026-08-0610-QQuarterly report pursuant to Section 13 or 15(d)2026-06-30SEC
2026-08-068-KCurrent report2026-08-06SEC
2026-07-29SCHEDULE 13G/ASEC
2026-06-2215-12GSEC
2026-06-22S-8Initial registration statement for securities to be offered to employees pursuant to employee benefit plansSEC
2026-06-124Statement of changes in beneficial ownership of securities2026-06-10SEC
2026-06-11144Filing for proposed sale of securities under Rule 144.SEC
2026-06-10144Filing for proposed sale of securities under Rule 144.SEC
2026-06-098-KCurrent report2026-06-05SEC
2026-06-094Statement of changes in beneficial ownership of securities2026-06-05SEC
2026-06-08144Filing for proposed sale of securities under Rule 144.SEC
2026-06-084Statement of changes in beneficial ownership of securities2026-06-04SEC
2026-06-084Statement of changes in beneficial ownership of securities2026-06-05SEC
2026-06-084Statement of changes in beneficial ownership of securities2026-06-05SEC
2026-06-084Statement of changes in beneficial ownership of securities2026-06-05SEC
2026-06-03144Filing for proposed sale of securities under Rule 144.SEC
2026-05-29SDSpecialized Disclosure ReportSEC
2026-05-0510-QQuarterly report pursuant to Section 13 or 15(d)2026-03-31SEC
2026-05-048-KCurrent report2026-05-04SEC
2026-04-234Statement of changes in beneficial ownership of securities2026-04-21SEC
2026-04-22ARSAnnual report to security holders. 2025-12-31SEC
2026-04-22DEFA14AProxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934SEC

Insider activity by month

MonthBoughtBuysSoldSells
2026-110000
2026-100000
2026-090000
2026-0800429.38K1
2026-070000
2026-06003.62M4
2026-050000
2026-040000
2026-0300471.26K8
2026-020000
2026-010000
2025-1200115.54K1
2025-110000

Institutional holders

Manager% owned
BlackRock, Inc.8.37%
CADIAN CAPITAL MANAGEMENT, LP5.79%
MORGAN STANLEY4.52%
VANGUARD CAPITAL MANAGEMENT LLC4.27%
MILLENNIUM MANAGEMENT LLC3.42%
FRED ALGER MANAGEMENT, LLC3.07%
GEODE CAPITAL MANAGEMENT, LLC2.79%
MAK CAPITAL ONE LLC2.53%
First Eagle Investment Management, LLC2.51%
STATE STREET CORP2.08%

Funds

Fund% owned
Multi-Asset Strategy Fund3.12%
VANGUARD TOTAL STOCK MARKET INDEX FUND3.02%
iShares Russell 2000 ETF2.56%
First Eagle Small Cap Opportunity Fund2.27%
ALGER SMALL CAP FOCUS FUND2.12%
Multi-Strategy Income Fund1.89%
Calamos Timpani Small Cap Growth Fund1.47%
VANGUARD EXTENDED MARKET INDEX FUND1.15%
Fidelity Small Cap Index Fund1.08%
Nuveen Quant Small Cap Equity Fund1.02%

OakChart. CYRX. Cached 15 minutes.